Clinical Trial Information Request for Protocol 25-764 Title A Phase 2, Randomized, Multicenter, Open-label, Blinded-endpoint Study to Evaluate the Safety of REGN7508 and REGN9933, Monoclonal Antibodies against FXI, versus Apixaban in Participants with Atrial Fibrillation (ROXI-ATLAS) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone